Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF-β-mediated effectBULUT, K; MEIER, J. J; ANSORGE, N et al.Regulatory peptides. 2004, Vol 121, Num 1-3, pp 137-143, issn 0167-0115, 7 p.Article

Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemiaMEIER, J. J; GALLWITZ, B; SIEPMANN, N et al.Diabetologia (Berlin). 2003, Vol 46, Num 6, pp 798-801, issn 0012-186X, 4 p.Article

Beta cell mass in diabetes : a realistic therapeutic target?MEIER, J. J.Diabetologia (Berlin). 2008, Vol 51, Num 5, pp 703-713, issn 0012-186X, 11 p.Article

Combined pancreas and kidney transplantation in a lean Type 2 diabetic patient. Effects on insulin secretion and sensitivityPOX, C; RITZEL, R; BÜSING, M et al.Experimental and clinical endocrinology & diabetes. 2002, Vol 110, Num 8, pp 420-424, issn 0947-7349, 5 p.Article

Do current incretin mimetics exploit the full therapeutic potential inherent in GLP-1 receptor stimulation?NAUCK, M. A; BARANOV, O; RITZEL, R. A et al.Diabetologia (Berlin). 2013, Vol 56, Num 9, pp 1878-1883, issn 0012-186X, 6 p.Article

Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humansMEIER, J. J; BUTLER, A. E; GALASSO, R et al.Diabetologia (Berlin). 2006, Vol 49, Num 11, pp 2689-2696, issn 0012-186X, 8 p.Article

Sustained beta cell apoptosis in patients with long-standing type 1 diabetes : indirect evidence for islet regeneration? CommentaryATKINSON, M. A; RHODES, C. J; MEIER, J. J et al.Diabetologia (Berlin). 2005, Vol 48, Num 11, pp 2200-2202, issn 0012-186X, 11 p.Article

Determinants of glucose control in patients with chronic pancreatitisSCHRADER, H; MENGE, B. A; ZEIDLER, C et al.Diabetologia (Berlin). 2010, Vol 53, Num 6, pp 1062-1069, issn 0012-186X, 8 p.Article

Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosisBUTLER, A. E; GALASSO, R; MEIER, J. J et al.Diabetologia (Berlin). 2007, Vol 50, Num 11, pp 2323-2331, issn 0012-186X, 9 p.Article

Influence of an antidiabetic treatment with sulfonylurea drugs on long-term Survival after acute myocardial infarction in Patients with type 2 diabetes: The LAngendreer Myocardial Infarction and Blood Glucose in Diabetic Patients Assessment (LAMBDA)MEIER, J. J; DEIFUSS, S; KLAMANN, A et al.Experimental and clinical endocrinology & diabetes. 2003, Vol 111, Num 6, pp 344-350, issn 0947-7349, 7 p.Article

The effects of acetylsalicylic acid on proliferation, apoptosis, and invasion of cyclooxygenase-2 negative colon cancer cells. CommentaryYU, H.-G; HUANG, J.-A; SCHMITZ, F et al.European journal of clinical investigation. 2002, Vol 32, Num 11, pp 793-794, issn 0014-2972, 11 p.Article

Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjectsMEIER, J. J; DEACON, C. F; SCHMIDT, W. E et al.Diabetologia (Berlin). 2007, Vol 50, Num 4, pp 806-813, issn 0012-186X, 8 p.Article

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms. CommentaryNAUCK, M. A; MEIER, J. J; T'HART, L. M et al.Diabetologia (Berlin). 2007, Vol 50, Num 12, issn 0012-186X, 2413-2416, 2443-2450 [12 p.]Article

Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetesMEIER, J. J; LIN, J. C; BUTLER, A. E et al.Diabetologia (Berlin). 2006, Vol 49, Num 8, pp 1838-1844, issn 0012-186X, 7 p.Article

Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humansMEIER, J. J; GETHMANN, A; GÖTZE, O et al.Diabetologia (Berlin). 2006, Vol 49, Num 3, pp 452-458, issn 0012-186X, 7 p.Article

Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humansMEIER, J. J; BREUER, T. G. K; BONADONNA, R. C et al.Diabetologia (Berlin). 2012, Vol 55, Num 5, pp 1346-1354, issn 0012-186X, 9 p.Article

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?NAUCK, M. A; VARDARLI, I; DEACON, C. F et al.Diabetologia (Berlin). 2011, Vol 54, Num 1, pp 10-18, issn 0012-186X, 9 p.Article

Metabolic consequences of a 50% partial pancreatectomy in humansMENGE, B. A; SCHRADER, H; BREUER, T. G. K et al.Diabetologia (Berlin). 2009, Vol 52, Num 2, pp 306-317, issn 0012-186X, 12 p.Article

Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?MEIER, J. J; GALLWITZ, B; SCHMIDT, W. E et al.Heart (London 1996). 2004, Vol 90, Num 1, pp 9-12, issn 1355-6037, 4 p.Article

Appetitregulation durch Ghrelin -ein neues neuroendokrines gastrales Peptidhormon der Gut-Brain-Achse = Appetite regulation by Ghrelin - a novel neuro-endocrine gastric peptidhormone in the gut-brain-axisHAGEMANN, D; MEIER, J. J; GALLWITZ, B et al.Zeitschrift für Gastroenterologie. 2003, Vol 41, Num 9, pp 929-936, issn 0044-2771, 8 p.Article

A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndromeNAUCK, M. A; MEIER, J. J; WOLFERSDORFF, A. V et al.Acta diabetologica (Print). 2003, Vol 40, Num 4, pp 163-172, issn 0940-5429, 10 p.Article